Home LiteratureArticle Details
PMID: 7588611 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.

The EMBO journal ·Vol. 14 ·No. 19 ·1995-10-02 ·Pages 4814-26

Steiner P, Philipp A, Lukas J, Godden-Kent D, Pagano M, Mittnacht S, Bartek J, Eilers M

Abstract

Activation of conditional alleles of Myc can induce proliferation in quiescent cells. We now report that induction of Myc in density-arrested fibroblasts triggers rapid hyperphosphorylation of the retinoblastoma protein and activation of both cyclin D1- and cyclin E-associated kinase activities in the absence of significant changes in the amounts of cyclin-cdk complexes. Kinase activation by Myc is blocked by inhibitors of transcription and requires intact DNA binding and heterodimerization domains of Myc. Activation of cyclin E-cdk2 kinase in serum-starved cells occurs in two steps. The first is induced by Myc and involves the release of a 120 kDa cyclin E-cdk2 complex from a 250 kDa inactive complex that is present in starved cells. This is necessary, but not sufficient, to generate full kinase activity, as cdc25 phosphatase activity is limiting in the absence of external growth factors. In vivo cdc25 activity can be supplied by the addition of growth factors. In vitro recombinant cdc25a strongly activates the 120 kDa, but only poorly activates the 250 kDa cyclin E-cdk2 complex. Our data show that two distinct signals, one of which is supplied by Myc, are necessary for consecutive steps during growth factor-induced formation of active cyclin E-cdk2 complexes in G(o)-arrested rodent fibroblasts.

MeSH Terms
Animals CDC2-CDC28 Kinases Cell Cycle Proteins/metabolism Cell Line Cyclin D1 Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinases/biosynthesis,metabolism Cyclins/biosynthesis,metabolism Enzyme Activation Fibroblasts Genes, myc Growth Substances/blood,physiology Oncogene Proteins/biosynthesis,metabolism Phosphoprotein Phosphatases/metabolism Phosphorylation Protein Serine-Threonine Kinases/biosynthesis,metabolism Proto-Oncogene Proteins c-myc/physiology RNA, Messenger/biosynthesis Rats Retinoblastoma Protein/metabolism S Phase cdc25 Phosphatases
Chemicals
Cell Cycle Proteins Cyclins Growth Substances Oncogene Proteins Proto-Oncogene Proteins c-myc RNA, Messenger Retinoblastoma Protein Cyclin D1 Protein Serine-Threonine Kinases CDC2-CDC28 Kinases Cdk2 protein, rat Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinases Phosphoprotein Phosphatases cdc25 Phosphatases
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Steiner P
Zentrum für Molekulare Biologie Heidelberg (ZMBH), Germany
Philipp A
Lukas J
Godden-Kent D
Pagano M
Mittnacht S
Bartek J
Eilers M
References (82)
82 references, click to expand
  1. The functions of Myc proteins.
    Biochim Biophys Acta. 1992 Dec 16;1114(2-3):129-46 PMID: 1457461
  2. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
    Cell. 1993 Jan 29;72(2):211-22 PMID: 8425218
  3. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
    Cell. 1993 Jan 29;72(2):223-32 PMID: 8425219
  4. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.
    Genes Dev. 1993 Apr;7(4):671-82 PMID: 8458579
  5. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.
    J Cell Biol. 1993 Apr;121(1):101-11 PMID: 8458862
  6. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
    Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2935-9 PMID: 8385351
  7. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen.
    Mol Endocrinol. 1993 Feb;7(2):232-40 PMID: 8469236
  8. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15.
    Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3521-4 PMID: 8475101
  9. Differential modulation of cyclin gene expression by MYC.
    Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3685-9 PMID: 8386381
  10. Cyclin D1 is a nuclear protein required for cell cycle progression in G1.
    Genes Dev. 1993 May;7(5):812-21 PMID: 8491378
  11. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
    Cell Growth Differ. 1993 Feb;4(2):57-65 PMID: 8494784
  12. Proliferative activation of quiescent Rat-1A cells by delta FosB.
    Mol Cell Biol. 1993 Jul;13(7):4157-66 PMID: 8321220
  13. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.
    EMBO J. 1992 Nov;11(11):3995-4005 PMID: 1396589
  14. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts.
    Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9910-4 PMID: 1409718
  15. Association of human cyclin E with a periodic G1-S phase protein kinase.
    Science. 1992 Sep 25;257(5078):1958-61 PMID: 1329201
  16. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
    Genes Dev. 1993 Aug;7(8):1559-71 PMID: 8339933
  17. The ornithine decarboxylase gene is a transcriptional target of c-Myc.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7804-8 PMID: 8356088
  18. Signals and genes in the control of cell-cycle progression.
    Biochim Biophys Acta. 1993 Aug 23;1155(2):151-79 PMID: 8357825
  19. Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.
    Genes Dev. 1995 May 1;9(9):1046-58 PMID: 7744247
  20. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.
    Nucleic Acids Res. 1995 May 25;23(10):1686-90 PMID: 7784172
  21. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence.
    Genes Dev. 1992 Dec;6(12B):2513-23 PMID: 1340466
  22. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  23. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Oncogene. 1993 Dec;8(12):3447-57 PMID: 8247550
  24. p21 is a universal inhibitor of cyclin kinases.
    Nature. 1993 Dec 16;366(6456):701-4 PMID: 8259214
  25. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Nature. 1993 Dec 16;366(6456):704-7 PMID: 8259215
  26. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.
    Nature. 1993 Dec 16;366(6456):707-10 PMID: 8259216
  27. Distinct roles for cyclin-dependent kinases in cell cycle control.
    Science. 1993 Dec 24;262(5142):2050-4 PMID: 8266103
  28. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
    Genes Dev. 1994 Jan;8(1):9-22 PMID: 8288131
  29. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
    Oncogene. 1994 Jan;9(1):323-6 PMID: 8302597
  30. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.
    Oncogene. 1994 Mar;9(3):707-18 PMID: 8108113
  31. D-type cyclin-dependent kinase activity in mammalian cells.
    Mol Cell Biol. 1994 Mar;14(3):2066-76 PMID: 8114738
  32. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
    Mol Cell Biol. 1994 Mar;14(3):2077-86 PMID: 8114739
  33. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    Cancer Res. 1994 Mar 1;54(5):1169-74 PMID: 8118801
  34. Inducible regulatory elements in the human cyclin D1 promoter.
    Oncogene. 1994 Apr;9(4):1295-304 PMID: 8134134
  35. Cdc25A is a novel phosphatase functioning early in the cell cycle.
    EMBO J. 1994 Apr 1;13(7):1549-56 PMID: 8156993
  36. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    J Cell Biol. 1994 May;125(3):625-38 PMID: 8175885
  37. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death.
    Curr Opin Genet Dev. 1994 Feb;4(1):102-8 PMID: 8193530
  38. An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc.
    Mol Cell Biol. 1994 Jun;14(6):3853-62 PMID: 8196628
  39. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.
    Proc Natl Acad Sci U S A. 1982 Apr;79(8):2490-4 PMID: 6283530
  40. Differential expression of the amv gene in human hematopoietic cells.
    Proc Natl Acad Sci U S A. 1982 Apr;79(7):2194-8 PMID: 6954533
  41. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.
    Cell. 1983 Dec;35(3 Pt 2):603-10 PMID: 6606489
  42. Functional role for c-myc in mitogenic response to platelet-derived growth factor.
    Nature. 1984 Aug 23-29;310(5979):655-60 PMID: 6088986
  43. Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals.
    Cell. 1984 Dec;39(2 Pt 1):339-48 PMID: 6498938
  44. The regulation and expression of c-myc in normal and malignant cells.
    Annu Rev Immunol. 1986;4:317-38 PMID: 3518746
  45. A microinjected monoclonal antibody against human DNA polymerase-alpha inhibits DNA replication in human, hamster, and mouse cell lines.
    J Biol Chem. 1986 Aug 15;261(23):10802-7 PMID: 3733734
  46. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.
    Mol Cell Biol. 1985 Dec;5(12):3610-6 PMID: 3915782
  47. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.
    Cell. 1986 Oct 10;47(1):11-8 PMID: 3093082
  48. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor.
    EMBO J. 1986 Sep;5(9):2231-6 PMID: 3780678
  49. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts.
    Mol Cell Biol. 1986 Jun;6(6):1917-25 PMID: 3785184
  50. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
    Nature. 1987 Jul 30-Aug 5;328(6129):445-9 PMID: 3302722
  51. A safe packaging line for gene transfer: separating viral genes on two different plasmids.
    J Virol. 1988 Apr;62(4):1120-4 PMID: 2831375
  52. Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences.
    DNA. 1988 Apr;7(3):219-25 PMID: 2836147
  53. c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells.
    Mol Cell Biol. 1988 Sep;8(9):3683-95 PMID: 2464742
  54. 'Nuclear' oncogenes convert extracellular stimuli into changes in the genetic program.
    Trends Genet. 1989 Apr;5(4):112-5 PMID: 2658225
  55. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells.
    Nature. 1989 Jul 6;340(6228):66-8 PMID: 2662015
  56. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.
    EMBO J. 1990 Sep;9(9):2811-8 PMID: 2118104
  57. The MYC protein activates transcription of the alpha-prothymosin gene.
    EMBO J. 1991 Jan;10(1):133-41 PMID: 1989881
  58. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Science. 1991 Mar 8;251(4998):1211-7 PMID: 2006410
  59. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation.
    Cell. 1991 May 3;65(3):395-407 PMID: 1840505
  60. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product.
    Nature. 1991 Aug 8;352(6335):541-4 PMID: 1865909
  61. Overexpression of c-jun, junB, or junD affects cell growth differently.
    Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8890-4 PMID: 1924349
  62. Myc and Max associate in vivo.
    Genes Dev. 1992 Jan;6(1):71-80 PMID: 1730411
  63. Induction of apoptosis in fibroblasts by c-myc protein.
    Cell. 1992 Apr 3;69(1):119-28 PMID: 1555236
  64. Repression of cyclin D1: a novel function of MYC.
    Mol Cell Biol. 1994 Jun;14(6):4032-43 PMID: 8196642
  65. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oncogene. 1994 Jul;9(7):2029-36 PMID: 8208548
  66. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
    Cell. 1994 Jul 15;78(1):59-66 PMID: 8033212
  67. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
    Cell. 1994 Jul 15;78(1):67-74 PMID: 8033213
  68. Participation of cyclin A in Myc-induced apoptosis.
    Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6875-9 PMID: 8041712
  69. Effects of c-myc expression on cell cycle progression.
    Mol Cell Biol. 1994 Sep;14(9):5748-55 PMID: 8065309
  70. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase.
    Cell. 1994 Aug 26;78(4):713-24 PMID: 8069918
  71. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.
    Nature. 1994 Sep 15;371(6494):257-61 PMID: 8078588
  72. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.
    EMBO J. 1994 Sep 15;13(18):4302-10 PMID: 7523110
  73. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.
    Mol Cell Biol. 1994 Nov;14(11):7265-75 PMID: 7935441
  74. G1 phase progression: cycling on cue.
    Cell. 1994 Nov 18;79(4):551-5 PMID: 7954821
  75. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein.
    Genes Dev. 1994 Aug 1;8(15):1759-71 PMID: 7958855
  76. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle.
    Oncogene. 1994 Dec;9(12):3635-45 PMID: 7526316
  77. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.
    Nature. 1994 Dec 8;372(6506):570-3 PMID: 7990932
  78. Principles of CDK regulation.
    Nature. 1995 Mar 9;374(6518):131-4 PMID: 7877684
  79. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.
    Cell. 1995 Mar 10;80(5):767-76 PMID: 7889570
  80. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3.
    Cell. 1995 Mar 10;80(5):777-86 PMID: 7889571
  81. The retinoblastoma protein and cell cycle control.
    Cell. 1995 May 5;81(3):323-30 PMID: 7736585
  82. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Science. 1995 Aug 4;269(5224):682-5 PMID: 7624798
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1995-10-02
Pages
4814-26
Language
English
Region
England
NLM ID
8208664
PMCID
PMC394579
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]